MaxRets Ventures PLC Change of Name to MaxRets Ventures plc (0887P)
07 Febrero 2023 - 1:00AM
UK Regulatory
TIDMMAX
RNS Number : 0887P
MaxRets Ventures PLC
07 February 2023
7 February 2023
Greencare Capital PLC
("Greencare" or "the Company")
(To be re-named MaxRets Ventures plc)
Change of Name
Greencare is pleased to announce that, following approval by
shareholders at a General Meeting of the Company held on 28
December 2022 to change the Company name, and under the Company's
Articles of Association which empower the Directors to amend such
name, Greencare is henceforth renamed MaxRets Ventures plc.
The new Company name has been formally registered at Companies
House and a Certificate of Incorporation on Change of name issued.
The change of name will take effect on the AQUIS Stock Exchange
Growth Market (ASX) from 8.00am today, 7 February, 2023 and
dealings under the new name will commence immediately
thereafter.
The Company's TIDM will also change to MAX. Its ISIN (
GB00BJBYK814 ) remains unchanged.
The Company's website address (which includes the information
required by AQSE Rule 4.14) has changed to: www.maxrets.com .
Shareholders will be unaffected by the change of name, and
existing share certificates remain valid and should be
retained.
Enquiries:
MaxRets Ventures plc c/o Walbrook PR Ltd
Dominic White, Chairman
Cairn Financial Advisers LLP
AQSE Corporate Adviser
Jo Turner / James Lewis +44 (0)20 7213 0880
Walbrook PR Limited +44 (0)20 7933 8780
Paul Vann / Nick Rome / Joe Walker +44 (0)7768 807631
maxrets@walbrookpr.com
Notes:
Change of Investing Strategy
The Board of Greencare firmly believes that, as a result of the
current challenging global economic and geopolitical landscape,
opportunities now exist to invest in or acquire distressed or out
of favour assets which have become undervalued, or, assets which
may benefit from consolidation. The Company's underlying investment
driver will be technology driven businesses based on their
potential future value enhancement and investment returns. The
Board has identified four sectors of initial focus, and will likely
in future target other technology driven sectors. These initial
sectors include Life Sciences, fintech businesses and assets that
use fintech , Impact Investing (Environmental and Renewables) and
Retail.
It is the Board's intention, following shareholder approval, to
implement a growth incubator and pre-IPO investment philosophy as
its investment strategy, whereby it will seek out early stage or
undervalued later stage businesses with strong upside potential,
with the objective of acquiring, funding, growing and selling-on
the investments through the public markets at enhanced
valuations.
The board will not restrict the jurisdiction of investments
since the application of technology is not constrained by
geographic borders, however, the Board would expect that it will
consider more investments in Europe.
Structure of Investments
Following the passing of the Resolutions, the Company
anticipates that investments will be made from the Company's own
balance sheet and/or in partnership with other investing entities
and will be expected to be in the form of equity and equity-related
instruments, including convertible debt instruments, and, debt. The
Company may offer its ordinary shares and debt instruments in
exchange for shares in investee businesses.
The Company may invest in quoted or listed companies, that are
publicly traded, and private companies. It may acquire investments
directly or by way of holdings in intermediate holding or
subsidiary entities. The Company may also invest in limited
liability partnerships and other forms of legal entity.
The Company may invest in majority or minority positions and
will ensure that it has suitable investor protection rights, as
determined by the Board.
The Company may, where appropriate and deemed by the Directors
to be in the Company's best interests, seek a position on the
boards of investee companies to actively monitor and assist the
business including helping to scale senior management, inform and
refine strategy, drive key performance indicators and provide
guidance on future financing.
The Company intends to realise value through exiting the
investments over time and will have no fixed investment period.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NEXEAFAKEFNDEAA
(END) Dow Jones Newswires
February 07, 2023 02:00 ET (07:00 GMT)
MaxRets Ventures (AQSE:MAX)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
MaxRets Ventures (AQSE:MAX)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024